Welcome to LookChem.com Sign In|Join Free

CAS

  • or

119881-02-6

Post Buying Request

119881-02-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

119881-02-6 Usage

General Description

Boc-Aminomalonic acid is a specialty chemical compound primarily used in medical and scientific research, particularly in the creation of certain types of protective group reagents for amino acids. It is an aminomalonic acid derivative with a Boc (tert-butoxycarbonyl) protective group, which makes it stable and less reactive in various chemical environments, facilitating its use in complex chemical syntheses. Moreover, its unique reactivity and structure make it a valuable asset in the development of different pharmaceuticals. However, like many similar compounds, it must be handled carefully due to potential hazards and toxicity.

Check Digit Verification of cas no

The CAS Registry Mumber 119881-02-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,9,8,8 and 1 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 119881-02:
(8*1)+(7*1)+(6*9)+(5*8)+(4*8)+(3*1)+(2*0)+(1*2)=146
146 % 10 = 6
So 119881-02-6 is a valid CAS Registry Number.

119881-02-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-[(2-methylpropan-2-yl)oxycarbonylamino]propanedioic acid

1.2 Other means of identification

Product number -
Other names tert-butyloxycarbonylaminomalonic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:119881-02-6 SDS

119881-02-6Relevant articles and documents

Glutathione peroxidase-like activity of amino-substitutedwater-soluble cyclic selenides: A shift of the major catalytic cycle in methanol

Arai, Kenta,Tashiro, Ayako,Osaka, Yuui,Iwaoka, Michio

supporting information, (2017/03/09)

We previously reported that water-soluble cyclic selenides can mimic the antioxidative function of glutathione peroxidase (GPx) in water through a simple catalytic cycle, in which the selenide (>Se) is oxidized by H2O2 to the selenoxide (>Se=O) and the selenoxide is reduced by a thiol back to the selenide. In methanol, however, the GPx-like activity could not be explained by this simple scenario. To look into the reasons for the unusual behaviors in methanol, monoamino-substituted cyclic selenides with a variable ring size were synthesized, and the intermediates of the catalytic cycle were characterized by means of 77Se-NMR and LC-MS spectroscopies. In water, it was confirmed that the selenide and the selenoxide mainly contribute to the antioxidative function, though a slight contribution from the dihydroxy selenane (>Se(OH)2) was also suggested. In methanol, on the other hand, other active species, such as hydroxyselenonium (>Se+-OH) and hydroxy perhydroxy selenane (>Se(OH)(OOH)), could be generated to build another catalytic cycle. This over-oxidation would be more feasible for amino-substituted cyclic selenides, probably because the ammonium (NH3 +) group would transfer a proton to the selenoxide moiety to produce a hydroxyselenonium species in the absence of an additional proton source. Thus, a shift of the major catalytic cycle in methanol would make the GPx-like antioxidative function of selenides perplexing.

Amidomalonamides useful as inhibitors of MMP of matrix metalloproteinase

-

, (2008/06/13)

The present application relates to novel aminomalonamides of the formula and pharmaceutical composition thereof which are useful for inhibiting matrix metalloproteinases.

RENIN INHIBITORS IV

-

, (2008/06/13)

The invention concerns novel renin-inhibitory peptides which are useful for treating renin-assocated hypertension, hyperaldosteronism, and congestive heart failure. Processes for preparing the peptides, compositions containing them and methods of using them are included. Also included is a diagnostic method which uses the compounds to determine the presence of renin-associated hypertension or hyperaldosteronism.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 119881-02-6